4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer

4D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory biomarker collaborator in the Phase II DAD-IO clinical study (NCT04724018) led by Dana-Farber Cancer Institute and supported by Gilead Sciences, Inc. This high-profile study is evaluating a novel combination therapy for patients with locally advanced or metastatic urothelial carcinoma (mUC), including bladder cancer, and represents an important step forward in 4D Path’s mission to redefine precision oncology.

Hovione’s people-first approach recognized as it achieves Top Employer certification for the fourth consecutive year

Hovione, an international integrated pharmaceutical development and manufacturing organization, has achieved Top Employer certification across all four of its manufacturing sites worldwide for the fourth consecutive year.

CluePoints Appoints New Chief People Officer to Support Next Phase of Global Growth

CluePoints, provider of leading statistical and AI-driven software solutions, has appointed Sinead Godkin as its new Chief People Officer (CPO).

ELRIG Announces Drs Stephen Ward and Annarita Miccio as Keynote Speakers for Cell and Gene Therapy 2026

• Inaugural event takes place from 9–10 March at Hinxton Hall in Cambridge, UK • Programme spans neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy

VoxCell appoints Chief Commercial Officer as Demand Grows for Predictive, Human-Relevant, Non-Clinical Testing Approaches

Kindeva Announces Leadership Transition to Drive Strategic Growth

PHC Corporation of North America Launches TwinGuard® ECO 703VXH Freezer, Bringing New Energy Efficiency to Research Sample Protection

The PHCbi TwinGuard® ECO freezer ultra-low temperature (ULT) freezer is engineered to deliver enhanced energy efficiency and expanded operational monitoring for biorepositories, biopharmaceutical companies, and academic institutions.

Viz.ai and Salesforce Collaborate to Transform Pharma Engagement With Real-Time Clinical Intelligence for Agentforce

Supports customers with real-time clinical intelligence activation through Viz.ai’s integrated clinical workflows, triggers, and compliant orchestration services for Agentforce.

Advanced Health Selects 1upHealth to Lead Interoperability Initiatives

Sapio Sciences announces partner ecosystem for ELaiN, its third-generation AI lab notebook

Sapio Sciences has announced a growing partner ecosystem for Sapio ELaiN, its third-generation AI lab notebook, integrating trusted, third-party scientific applications and platforms directly into the workflow. These integrations allow biopharma scientists to use established tools for modeling, analytics and discovery inside ELaiN while maintaining governance, traceability and control.

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT’s firefly platform

Gifthealth Announces Jeremy Richardson as New Chief Commercial Officer

Gifthealth has announced the appointment of Jeremy Richardson as its new Chief Commercial Officer (CCO).

Astoriom Appoints Will Edwards as Chief Executive Officer

Strategic appointment to support global scale-up of sample management operations

Firstsource Acquires TeleMedik

From Tokyo to Osaka: PSI Continues Japan Expansion with New Office in Osaka

Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products

IDT and Ansa announced that Ansa’s Clonal DNA and XL Clonal DNA products, ranging from 100 bp to 50 kb, will be made available to IDT customers. This strategic collaboration enables more researchers to design and assemble longer, more complex constructs for next-generation cell and gene therapy discovery, vaccine research, and agrigenomics applications.

Hongene Biotech Announces Grant to Expand Global Access to mRNA Vaccine Raw Materials

Cellistic Launches Three New iPSC-based GMP Manufacturing Platforms to advance Immuno-Oncology and Regenerative Cell Therapies

Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting (CINV)

Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 Months